Haemonetics CorporationHAENYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+7.5%
5Y CAGR+4.2%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+7.5%/yr
Quarterly compound
5Y CAGR
+4.2%/yr
Recent acceleration
Percentile
P97
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 9.16% |
| Q3 2025 | -2.70% |
| Q2 2025 | 9.91% |
| Q1 2025 | -7.47% |
| Q4 2024 | 4.44% |
| Q3 2024 | -2.84% |
| Q2 2024 | -5.98% |
| Q1 2024 | 1.73% |
| Q4 2023 | 5.47% |
| Q3 2023 | 2.98% |
| Q3 2023 | 5.50% |
| Q1 2023 | 5.54% |
| Q4 2022 | 7.38% |
| Q4 2022 | -4.87% |
| Q3 2022 | 2.59% |
| Q1 2022 | 2.51% |
| Q1 2022 | 4.50% |
| Q4 2021 | 0.04% |
| Q3 2021 | -6.11% |
| Q1 2021 | 2.92% |
| Q4 2020 | 7.47% |
| Q3 2020 | 9.15% |
| Q2 2020 | 3.49% |
| Q1 2020 | 2.77% |
| Q4 2019 | -1.26% |
| Q3 2019 | -3.00% |
| Q2 2019 | -9.51% |
| Q1 2019 | 4.65% |
| Q4 2018 | -7.94% |
| Q3 2018 | 5.08% |
| Q2 2018 | -9.13% |
| Q1 2018 | -8.17% |
| Q4 2017 | 1.78% |
| Q3 2017 | 3.34% |
| Q3 2017 | 3.58% |
| Q1 2017 | -4.58% |
| Q4 2016 | 2.25% |
| Q4 2016 | 3.96% |
| Q3 2016 | -0.93% |
| Q1 2016 | -0.17% |